Antagonism between Two Mechanisms of Antifungal Drug Resistance
- 1 August 2006
- journal article
- Published by American Society for Microbiology in Eukaryotic Cell
- Vol. 5 (8) , 1243-1251
- https://doi.org/10.1128/ec.00048-06
Abstract
This study tested for interaction between two independently evolved mechanisms of fluconazole resistance in Saccharomyces cerevisiae . One set of strains was from a 400-generation evolution experiment, during which the concentration of fluconazole was increased from 16 to 256 μg/ml in four increments. At 100 generations, populations became fixed for resistance mutations in either of two transcriptional regulators, PDR1 or PDR3 . At 400 generations, replicate populations became fixed for another resistance mutation in UNK1 , an unmapped gene further increasing resistance. Another genotype used in this study came from a population placed initially in 128 μg/ml of fluconazole; this environment selects for resistance through loss of function at ERG3 , resulting in altered sterol metabolism. Mutant strains carrying PDR1 r or PDR3 r were crossed with the erg3 r mutant strain, and the doubly mutant, haploid offspring were identified. The double-mutant strains grew less well than the parent strains at all concentrations of fluconazole tested. In genome-wide assays of gene expression, several ABC transporter genes that were overexpressed in one parent and several ERG genes that were overexpressed in the other parent were also overexpressed in the double mutants. Of the 43 genes that were consistently overexpressed in the PDR1 r parents at generation 100, however, 31 were not consistently overexpressed in the double mutants. Of these 31 genes, 30 were also not consistently overexpressed after a further 300 generations of evolution in the PDR1 r parent populations. The two independently evolved mechanisms of fluconazole resistance are strongly antagonistic to one another.Keywords
This publication has 14 references indexed in Scilit:
- Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse FungiScience, 2005
- Evolution of antifungal-drug resistance: mechanisms and pathogen fitnessNature Reviews Microbiology, 2005
- Haploidy, Diploidy and Evolution of Antifungal Drug Resistance in Saccharomyces cerevisiaeGenetics, 2004
- Genome-wide Expression Profiling of the Response to Polyene, Pyrimidine, Azole, and Echinocandin Antifungal Agents in Saccharomyces cerevisiaeJournal of Biological Chemistry, 2003
- Population genomics of drug resistance in Candida albicansProceedings of the National Academy of Sciences, 2002
- Functional dissection of Pdr1p, a regulator of multidrug resistance in Saccharomyces cerevisiaeMolecular Genetics and Genomics, 2002
- Molecular basis of resistance to azole antifungalsTrends in Molecular Medicine, 2002
- Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequencesThe Lancet Infectious Diseases, 2002
- The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiaeMicrobiology, 1999
- Anticancer Drugs, Ionophoric Peptides, and Steroids as Substrates of the Yeast Multidrug Transporter Pdr5pJournal of Biological Chemistry, 1996